CHRISTINE PLETKOVA: Open Payments
NPI 1831108885 · ALDIE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 39 payments from 17 companies in 2025. Trend: 2023 $671 · 2024 $1,078 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $131 |
| Corium, LLC | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Tris Pharma Inc | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $42 |
| Bausch Health US, LLC | 2 | $41 |
Products named: Azstarys, UZEDY, REXULTI, Jornay PM, INVEGA SUSTENNA, INGREZZA, CAPLYTA, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
